ADXN
Addex Therapeutics
ADXN
ADXN
5 hedge funds and large institutions have $5.42M invested in Addex Therapeutics in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$2.89M |
| 2 |
UBS Group
Zurich,
Switzerland
|
$14K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $2.89M | -$240K | -2,358 | -8% |
|
|
CC
2
Caxton Corporation
Princeton,
New Jersey
| $1.35M | – | – | – |
|
|
NMC
3
NEA Management Company
Timonium,
Maryland
| $914K | – | – | – |
|
|
NLVP
4
New Leaf Venture Partners
New York
| $254K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $14K | -$72.5K | -725 | -84% |
|